Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bio-Rad Laboratories, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BIO
New York
3840
www.bio-rad.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bio-Rad Laboratories, Inc.
[Latest] Global Malaria Diagnostics Market Size/Share Worth USD 1.45 Billion by 2035 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- Mar 4th, 2026 12:30 pm
[Latest] Global Microplate Systems Market Size/Share Worth USD 2.88 Billion by 2035 at a 10.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- Mar 3rd, 2026 4:30 pm
Microfluidics Research Report 2026-2035: A $20.73 Billion Market by 2030 with Thermo Fisher Scientific, PerkinElmer, Dolomite, Agilent Technologies, Bio-Rad Laboratories, and Fluidigm Leading
- Feb 23rd, 2026 3:48 am
International Markets and Bio-Rad (BIO): A Deep Dive for Investors
- Feb 20th, 2026 7:15 am
Bio-Rad Laboratories, Inc. (BIO) Achieves Modest Revenue Growth and Robust Free Cash Flow Growth
- Feb 19th, 2026 12:42 pm
Bio-Rad's Q4 Earnings Miss Estimates, Revenues Surpass, Stock Down
- Feb 19th, 2026 6:33 am
Is It Time To Reassess Bio-Rad Laboratories (BIO) After Multi Year Share Price Weakness
- Feb 15th, 2026 3:09 pm
Assessing Bio-Rad Laboratories (BIO) Valuation After Prolonged Share Price Weakness
- Feb 15th, 2026 11:07 am
Bio-Rad Laboratories (BIO) Returns To Profitability With Diagnostics Rebound – Is The Turnaround Durable?
- Feb 15th, 2026 5:08 am
Bio-Rad Laboratories, Inc. Q4 2025 Earnings Call Summary
- Feb 13th, 2026 6:30 am
Bio-Rad Laboratories Inc (BIO) Q4 2025 Earnings Call Highlights: Navigating Growth and Challenges
- Feb 12th, 2026 10:02 pm
Bio-Rad Laboratories Q4 Earnings Call Highlights
- Feb 12th, 2026 8:10 pm
Bio-Rad (BIO) Q4 2025 Earnings Call Transcript
- Feb 12th, 2026 4:27 pm
Bio-Rad: Q4 Earnings Snapshot
- Feb 12th, 2026 3:59 pm
Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates
- Feb 12th, 2026 3:35 pm
Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results
- Feb 12th, 2026 2:15 pm
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026
- Jan 29th, 2026 6:30 am
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now
- Jan 21st, 2026 6:01 am
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference
- Jan 6th, 2026 6:45 am
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity
- Dec 12th, 2025 8:18 am
Scroll